Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Quercetin Phytosome
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : Thorne HealthTech
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Quercetin on Metabolic Health
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 25, 2022
Lead Product(s) : Quercetin Phytosome
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : Thorne HealthTech
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Meriva
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 12, 2021
Lead Product(s) : Meriva
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artichoke Extract
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
November 05, 2020
Lead Product(s) : Artichoke Extract
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gingko Biloba Extract
Therapeutic Area : Undisclosed
Study Phase : Phase II
Recipient : IRCCS San Raffaele
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of Ginkgo Biloba Leaf Extract
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 29, 2016
Lead Product(s) : Gingko Biloba Extract
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Recipient : IRCCS San Raffaele
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 06, 2015
Lead Product(s) : Artichoke Leaf Extract
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Undisclosed
Recipient : University of Mississippi Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 21, 2014
Lead Product(s) : Artichoke Leaf Extract
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Undisclosed
Recipient : University of Mississippi Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Samital
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 13, 2013
Lead Product(s) : Ginseng Extract
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effects of Ginseng on Cancer-Related Fatigue
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 17, 2011
Lead Product(s) : Ginseng Extract
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable